For example, researchers have found that HRASV12 expressing cancer cells are electively sensitive to ferroptosis, and KRAS silencing in KRAS mutant Calu-1 cells strongly reduces erastin sensibility (Yagoda et al., 2007). Here, KRAS is linked to cancer.